Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Baricitinib may effectively treat oral lichen planus.

Tofacitinib helped a woman regrow hair with no major side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Strontium ranelate is no longer available for treatment.

The treatment slightly increased hair growth and was safe for most women.

Intralesional steroid therapy is useful for treating various skin conditions.

Baricitinib helps treat severe hair loss in people over 65.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Researchers made a special butter with added betasitosterol that could be healthier for the heart and stayed good for three months.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.